These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25588253)

  • 1. Mechanisms of the neuromuscular blocking activity of the aminoglycoside antibiotic streptomycin.
    Brănişteanu DD; Sauciuc A; Proca B; Fuică A; Gogescu G
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(2):287-94. PubMed ID: 25588253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the aminoglycoside antibiotics, streptomycin and neomycin, on neuromuscular transmission. I. Presynaptic considerations.
    Fiekers JF
    J Pharmacol Exp Ther; 1983 Jun; 225(3):487-95. PubMed ID: 6306207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual action of ouabain on transmitter release at neuromuscular junctions of the frog.
    Brănişteanu DD; Proca B; Haulică ID
    J Pharmacol Exp Ther; 1979 Apr; 209(1):31-6. PubMed ID: 34716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sites of action of lead on spontaneous transmitter release from motor nerve terminals.
    Kolton L; Yaari Y
    Isr J Med Sci; 1982 Jan; 18(1):165-70. PubMed ID: 6121771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of different types of voltage-dependent calcium channels in evoked quantal transmitter release in frog neuromuscular junctions.
    Tsentsevitsky AN; Vasin AL; Bukharaeva EA; Nikolsky EE
    Dokl Biol Sci; 2008; 423():389-91. PubMed ID: 19213416
    [No Abstract]   [Full Text] [Related]  

  • 6. Sites and mechanisms of antibiotic-induced neuromuscular block: a pharmacological analysis using quantal content, voltage clamped end-plate currents and single channel analysis.
    Fiekers JF
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(4):242-50. PubMed ID: 10797867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium dependence of evoked transmitter release at very low quantal contents at the frog neuromuscular junction.
    Andreu R; Barrett EF
    J Physiol; 1980 Nov; 308():79-97. PubMed ID: 6112267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evoked transmitter release at the frog neuromuscular junction in the presence of very low extracellular Ca2+.
    Mosier DR; Zengel JE
    Neurosci Lett; 1994 Jun; 174(1):1-4. PubMed ID: 7970140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory role of intracellular sodium ions in neurotransmitter secretion.
    Melinek R; Lev-Tov A; Meiri H; Erulkar SD; Rahamimoff R
    Isr J Med Sci; 1982 Jan; 18(1):37-43. PubMed ID: 6121773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lindane upon transmitter release and end-plate responsiveness in the neuromuscular junction of the frog.
    Joy RM; Vogel SM; Narahashi T
    Neuropharmacology; 1987 Aug; 26(8):1223-9. PubMed ID: 2443872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase inhibitor okadaic acid enhances transmitter release at neuromuscular junctions.
    Abdul-Ghani M; Kravitz EA; Meiri H; Rahamimoff R
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1803-7. PubMed ID: 1672044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In botulinum type A-poisoned frog motor endings ouabain induces phasic transmitter release through Na+-Ca2+ exchange.
    Molgo J; Angaut-Petit D; Thesleff S
    Brain Res; 1987 May; 410(2):385-9. PubMed ID: 3036311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction.
    Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD
    Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual effect of calmidazolium (R 24571) on transmitter release at the frog neuromuscular junction.
    Sahaf ZY; Publicover SJ
    Brain Res; 1985 Nov; 348(1):192-6. PubMed ID: 2998560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of aminoglycoside-induced neuromuscular blockade by protons in vitro and in vivo.
    Talbot PA
    J Pharmacol Exp Ther; 1987 May; 241(2):686-94. PubMed ID: 3033223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presynaptic mechanisms of zinc effects on the neuromuscular transmission].
    Zefirov AL; Shakirianova DM; Cheranov SIu; Mukhamedzianov RD
    Ross Fiziol Zh Im I M Sechenova; 1999 May; 85(5):646-53. PubMed ID: 10511983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.